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Calcium phosphate apatites are naturally present in all vertebrates, as a biomineral in teeth and bones. The possibility to prepare synthetic 
analogs in close-to-physiological conditions allows the development of bio-inspired materials for medical use. While apatite-based biomaterials 
are extensively developed for bone regeneration, their intrinsic biocompatibility also allows designing original applications as in nanomedicine. 
In this paper, we will illustrate why colloidal apatite particles can be seen as a multifunctional platform for (nano)medical uses, well beyond 
bone repair. Retrospective data will be summarized in this mini-review, especially relating to oncology and hematology applications of apatite 
colloidal particles. Then novel data will be presented, in the field of dermatology and of particle tracking, using Raman confocal microscopy and 
µPIXE elemental mapping on substituted apatites. By exploiting their exceptional surface and bulk reactivities, colloidal apatite particles appear 
as robust new comers to nanomedicine, with the capacity to exhibit tailorable functionalities.
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Introduction
The mineral component of bones and teeth is composed 
of a calcium phosphate apatitic phase [1,2]. While enamel 
contains nearly stoichiometric, well-crystallized hydroxyapatite 
Ca10(PO4)6(OH)2, exhibiting a high thermodynamic stability well 
suited to face bacterial acidic attacks, bone apatite is in contrast 
composed of nonstoichiometric (calcium-and hydroxide-defi-
cient) nanocrystalline apatite more prone to undergo remodeling 
in vivo upon the controlled local acidic environment provided by 
resorptive osteoclastic cells [1]. Indeed, apatite solubility is direct-
ly related to its degree of stoichiometry [3]. The nonstoichiometry 
and nanocrystalline characters of bone apatite imply a high reac-
tivity that can be used by the organism for maintaining the appro-
priate ionic concentrations in body fluids (homeostasis). This is all 
the more facilitated by the high mobility of ions from the surface of 
apatite nanocrystals, which are included in an amorphous-like io-
nic hydrated layer on the surface of the nanocrystals [4-9]. Thanks 
to these features, it becomes possible to modulate the reactivity of 
biomimetic nanocrystalline apatite crystals by appropriate ionic 
substitutions and/or surface ion exchanges (e.g. [10]) and also via 
 
the adsorption of molecular species like antibiotics [11], enzymes 
[12], bisphosphonates [13] and anticancer drugs [14-16], among 
others. Indeed, the sorption of several types of drugs or biomole-
cules is facilitated on this type of apatitic compounds exhibiting 
high surface reactivity/ionic mobility/surface area versus other 
compounds like stoichiometric, well-crystallized hydroxyapatite. 
This possibility is especially appealing as it is possible to pre-
pare synthetic analogs to bone apatite via precipitation methods 
(e.g. [17-20]), e.g. using close-to-physiological conditions of preci-
pitation (temperature well below the water boiling point, pH close 
to 7.4). The bone-inspired character of such apatite compounds 
and their associated high reactivity has led to numerous studies, 
alone or combined with active agents/drugs, in the field of bone 
repair. More recently, the relevance of using such mineral phases 
in other domains than bone regeneration has however emerged 
and is now expanding by appropriation of the intrinsic qualities 
of bio-inspired apatites, namely their high biocompatibility, abi-
lity to modify ionic compositions and to adsorb various types of 
(bio)molecules and drugs. The present contribution will illustrate 
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their potential multifunctionality by summarizing some of the 
discoveries made in the use of apatite particles in nanomedicine, 
well beyond bone repair, as in oncology and hematology; and it 
will also present some new data in the field of dermatology and 
apatite particle tracking.
Results and discussion
In the field of nanomedicine, particles are expected to play a 
role at the tissue or cellular levels. Therefore, the control of the 
particle size is often a prerequisite to optimize the targeted effects 
and limit drawbacks such as clogging. As apatite compounds have 
a strong natural tendency to aggregate–which contributes to de-
crease the impact of surface energy – the first aspect that needs to 
be addressed is the control of the agglomeration state. Successful 
results were obtained by using stabilizing agents, forming an “or-
ganic corona” around the (mineral) apatite particles and contri-
buting to colloidal stabilization [21,22]. By exploiting a concept 
of steric hindrance and/or electrostatic repulsion between 
adjacent particles, it was indeed possible to obtain colloidal, in-
dividually-dispersed, apatite particles. Typical examples of rele-
vant biocompatible stabilizing agents were tabulated in ref. [21]. 
Phosphonated polyethyleneglycol (PEGp) was shown to exert ag-
glomeration control over the apatite particles in formation, and 
this effect was found to depend directly on the PEGp molecular 
weight. Typical particle sizes around 180 nm were for example 
obtained reproducibly. Other agents were found to impede more 
efficiently apatite agglomeration, such as phosphocholine, e.g. lea-
ding to apatite particles centered on 70 nm in size, or AEP (2-ami-
noethylphosphate). The latter was especially found to be effective 
to prepare nanometric apatite particles of sizes lower than 100 
nm, and typically down to 30–40 nm depending on the relative 
proportions used in the precipitation medium [22]. 
Replacement of the phosphate end group in AEP–interacting 
with the apatite surface – by a phosphonate group was shown in 
this case to give very similar sizes. While 30–40nm particles are 
well-suited to interact with cells, e.g. in view of internalization, 
larger dimensions may be more adapted to other applications, for 
example in dermatology. The variety of sizes listed above allows 
envisioning various different medical uses depending on clini-
cal needs. Large macromolecules such as DNA were also tested, 
leading to submicron particles (200–300 nm in length), and this 
approach is especially relevant in the scope of transfection appli-
cations where DNA delivery inside cells is needed [23]. Figure 1 
gives a schematic view of one individual particle, which can be 
considered as hybrid as it involves a mineral core (apatite) and 
an organic corona. This corona may, as mentioned above, involve 
stabilizing/dispersing agent(s) to allow colloidal dispersion; and 
as such, it represents a first way to modulate the particle behavior 
when contacted with a liquid medium. Other ways to modulate the 
particles behavior can be combined to this colloidal stabilization, 
so as to seek additional functionalities, as also illustrated on Figure 
1. One appealing ability is the possibility to interact more specifi-
cally with certain type(s) of cells. This issue can be addressed by 
adsorbing, besides the dispersing agent, another molecular spe-
cies exhibiting cell-targeting capabilities. Such targeting agents 
can for example be in the form of antibodies [24,25] or other mo-
lecular groups that can be recognized by cell membrane receptors. 
For example, folic acid (FA) is known to interact strongly with fo-
late receptors (FR) that are over expressed on the surface of some 
breast or ovary cancer cells [26,27].
Figure 1: Schematic view of the potential multifunctionality of colloidal apatite particles for (nano)medicine.
Preliminary adsorption of FA on AEP-stabilized apatite par-
ticles prior to contact with breast cancer cells was indeed shown 
to target more specifically FR+ cells (here ZR-75-2) compared to 
FR– cells (here T-47-D) [21]. The adsorption of drugs is also one 
appealing capability of such engineered particles that may be 
used as drug carriers. Adsorption of a chemotherapeutic anti-fo-
late drug, namely methotrexate (MTX), was for example shown 
to be feasible onto apatite crystals with an adsorption behavior 
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very similar to FA [14]. A property of the apatite phase, especially 
in a highly-divided state, is its capacity to adsorb a very large va-
riety of molecules, especially exhibiting charged end-groups. For 
instance, adsorption of other chemotherapeutics such as doxo-
rubicin (DOX) has also been investigated, along with the conse-
quential effect on cancer cell viability [15]. It may be added that 
the sorption of a combination of different drugs, as illustrated on 
Figure 1 as “drugs “A” and “B”, can also be considered as a way 
to allow local co-delivery of various active agents in the objective 
of synergistic effects at the relevant clinical site. Drug adsorption 
may also involve a “linker” (as represented in the case of drug “B” 
on Figure 1), which is a portion of the adsorbed molecule that may 
be cleaved on contact with some external stimulus like a drop in 
pH or the presence of specific circulating species, for example. The 
large possibilities offered by apatite particles in terms of versatile 
adsorption can also be appropriately exploited to modulate the lo-
cal behavior of cell membranes. 
This was recently demonstrated in the field of hematology, 
and more specifically for the cryoprotection of Red Blood Cells 
(RBC) [28]. The exposure of an organic corona exhibiting charged 
end-groups around the apatite colloidal particles may indeed 
modify the electrical properties of RBC membranes, in a rever-
sible non-destructive way, making it more permeable to small 
molecules like the glucose dimer “trehalose”, a cryoprotecting 
agent. By increasing drastically trehalose permeation across RBC 
membranes, cell viability greater than 90% was reached after a 
cycle of freezing down to liquid nitrogen temperature and subse-
quent rapid thawing to ambient conditions, which parallels what 
is now a days obtained using toxic glycerol as cryoprotecting mole-
cule [28,29]. This modified permeation was also shown on synthe-
tic lipid bilayers as simplified view of cell membranes, using FITC 
as “diffusing model drug” [28]. All of the above shows how the or-
ganic corona around apatite particles can modify their properties 
in terms of particle dimensions, cell targeting, local (co)delivery 
of drugs, smart linker-associated drug release, or else concerning 
their interaction with synthetic or biological membranes. In addi-
tion, the modification of the chemical composition of the crystal-
line core of the particles is also a way to convey new functionali-
ties to colloidal apatite particles (see Figure 1). One possibility is 
for example to confer to the particles some intrinsic luminescence 
features, as this can be used either in view of medical diagnosis 
(e.g. for tracking diseased cells having internalized the particles) 
or for the development of medical strategies using these particles, 
as in dermatology. 
Figure 2: Raman mapping on (fresh) porcine ear skin explant after application of PEGp-stabilized apatite particles (mean size 180 nm). The 
localization of the Eu3+-labeled apatite particles on top of the skin is clearly seen.
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The luminescence property is then typically conveyed by subs-
tituting part of the Ca2+ ions from the calcium phosphate apatite 
phase by luminescent lanthanides like Eu3+ (red emission) or Tb3+ 
(green emission) [23,30, 31]. Such ionic substitutions were found 
to be feasible at least up to a few at.% [32], even in the colloidal 
state [30, 31], and the luminescence features are characteristic of 
these lanthanide ions which exhibit a low toxicity, a long lumines-
cence lifetime (of the order of the millisecond compared to the 
autofluorescence of biological media of few nanoseconds) and a 
non-bleaching effect as opposed to organic dyes. The luminescent 
apatite particles can be used for example to follow the localization 
of the particles after application on skin. This approach was stu-
died here in the case of porcine ear skin explants, and using the 
photoluminescence of Eu3+ under a Raman microscope. Figure 2 
displays an example of 3D mapping obtained after applying onto 
fresh (non-frozen) ear skin a colloid composed of apatite particles 
stabilized with PEGp (MW 5200 g/mol) with an average size of 
180 nm. As seen on this figure, coupled histological, Raman and 
luminescence features allowed us to point out the superficial lo-
calization of the particles on top the skin. This, in turn, allows en-
visioning dermatological uses of such colloidal particles, in view 
of topical (skin surface) applications. Besides luminescent ions, 
other ionic species can also be exploited as dopants of apatite 
particles in view of following their localization within tissues or 
inside cells. The use of techniques other than luminescence detec-
tion is then required. 
Figure 3: Images of elemental distribution obtained by µPIXE on cryofixed HUVEC cells. HUVEC control cells (a) are compared to 
exposed cryofixed HUVEC cells. Cells were contacted with three concentrations of Sr-doped (50 at.%) apatite nanoparticles 
(≈25 nm) stabilized with AEP. 0mg/L (control), 0.1mg/L and  0.5mg/L. µPIXE elemental maps of Al, Si, P, K, Ca and Sr are depicted.




a) [NP] = 0 mg/L (control)
b) [NP] = 0.1 mg/L
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One appealing approach is the combination of µPIXE (Par-
ticle-induced X-ray emission) and RBS (Rutherford Backscattering 
Spectrometry) for elemental mapping and quantification purpo-
ses. µPIXE provides note only the chemical composition of the 
sample but also their elemental mapping (Figure 3). During the 
interaction with the exciting beam, the chemical elements under-
go atomic excitation-de-excitation processes that eventually lead 
to the emission of a photon which exhibits the characteristic en-
ergy of the atomic number of the excited element. Standard expe-
rimental setups and detectors used for µPIXE allow simultaneous 
quantification of all elements heavier that Na with a 1 to 10 µg.g-
1 dry masse detection limit. In this work, AEP-stabilized apatite 
particles doped with Sr2+ ions – via partial substitution of Ca2+ ions 
– were contacted with HUVEC cells and analyzed by µPIXE (Figure 
3). As may be seen, phosphorus is homogeneously distributed in 
the cell with a much higher concentration in the nucleus area (Fi-
gure 3, red), and potassium is homogeneously distributed in the 
cell volume (Figure 3, green). While P is overly present even in 
the control due to biochemical molecular contents (nucleic acids, 
proteins), an increase in Sr detection can be directly related to the 
internalization of the particles by HUVEC cells. Concomitantly, an 
increase in Ca can also be pointed out. The corresponding quanti-
tative data are reported on Figure 4. 
Figure 4: Single cell quantitative analyses by µPIXE for Sr-doped apatite nanoparticles internalized by HUVEC cells. Individual X-ray spectra 
calculated for cells shown in Figure 3 can be fitted in order to determine the P, Ca and Sr concentration at the cellular level (expressed in 
ng.cm-2). This feature is particularly interesting for Sr-doped apatite nanoparticles analysis where cellular concentrations usually show strong 
variations inside the same population. Exposure to 0.1 mg/L of Sr-doped apatite nanoparticles with 25 or 50 at.% substitution of calcium.
Besides particle tracking, the incorporated ions can also play 
a biological role, which may be relevant to the clinic. For example, 
ions such as Cu2+ or Zn2+ can be added as dopants to the apatite 
[33] so as to provide antibacterial and/or anti-inflammatory ef-
fects, among other properties. One interest in this approach can be 
a delayed therapeutic action: while active molecules/drugs grafted 
on the particle within the organic corona are prone to play their 
therapeutic role first, the retarded release of such doping ions in 
the apatitic structure will essentially occur in a subsequent step 
upon the apatite biodegradation process. Therefore, a dual-ki-
netic release may be expected with prolonged biological effects. 
Other properties from substituting ions or ionic clusters within 
the apatite structure can also be exploited. For example, magnetic 
properties can be provided by using iron-bearing apatite-based 
systems-that may also contain iron oxides clusters [14,15,34,35]. 
Conferring magnetic properties to the particles can be interesting 
from various viewpoints, whether for hyperthermia cancer the-
rapy or for helping the displacement of the particles to some clini-
cally relevant sites from a patient’s body via the application of an 
external magnetic field. Also, the release of drugs attached to the 
particles can be activated in an external magnetic field was shown 
for example for DOX-loaded magnetic apatite particles [15]. 
Finally, let us mention that in view of pharmaceutical use, the 
inclusion of apatite (nano)particles within a galenic formulation 
will often be necessary. The formulation can for example modu-
late the hydrophilic/hydrophobic behavior which may have an in-
cidence on tissue penetration and other processes in vivo. In this 
work, to illustrate this statement, an alginate gel was formulated 
containing a model drug, folic acid (FA) in two conditions: 
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a) using a simple FA solution dispersed in the gel and 
b) using PEGp-stabilized apatite particles with pre-ad-
sorbed FA, dispersed in the gel. 
Then the permeation of the gels across synthetic membranes 
supposed to mimic the cutaneous barrier was followed in dynamic 
conditions using permeation test cells: modified Franz diffusion 
system incorporating three in-line flow-through diffusion cells. In 
a preliminary step, for easier comparison, the viscosity of the gel 
containing FA in the dissolved form (without apatite particles) was 
increased by adding 7.5 mmol/L of Ca2+ ions in the form of calcium 
chloride so as to reach the viscosity of the gel containing the col-
loidal apatite particles, around 1.85Pa.s for a shear rate of 100s-1. 
Then the permeation of the gels, including or not the particles, was 
followed with two synthetic (hydrophilic) membranes with 0.05 
and 0.2 µm porosities (Figure 5). As may be seen by comparing Fi-
gures 5a & 5b, a clear decrease of the particles permeation can be 
detected when they are included in the gel (e.g. 27% permeation 
at 100min, Figure 5b) compared to the particles only suspended in 
water (e.g. 90% permeation at 100min, Figure 5a), and whatever 
the membrane porosity studied. 
Figure 5: Permeation of FA across synthetic hydrophilic membranes (0.05 and 0.2µm porosities), in dynamic conditions for FA-
functionalized colloidal apatite particles in aqueous solution and included in an alginate gel (b). The permeation of FA simply dissolved in 
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This result points out the clear effect on permeation played by 
the formulation of colloidal apatite particles. Also, it may be noted 
on Figure 5b that, in the gel state, adsorption of the drug-modeled 
here by FA-onto the apatite particles limits its diffusion across the 
membrane compared to the drug simply dissolved in the gel for-
mulation. This may be relevant for favoring surface topical thera-
peutic effects for example in dermatology.
Concluding Remarks
This paper was intended as a mini-review pointing to the very 
versatile (nano)medical platform represented by bio-inspired 
apatite particles. Key reference works have been cited throughout 
the text to illustrate this, and allow the reader to obtain further 
details. In addition to their intrinsic biocompatibility due to simi-
larity to bone apatite, the exceptional surface and bulk reactivity 
of colloidal apatite particles can be exploited to provide “à la carte” 
functionalities such as cell targeting, smart delivery of drugs/ac-
tive agents, tailored interaction with cell membranes, lumines-
cence and other tracking features, as well as magnetism. Plus, 
their pharmaceutical formulation may allow modulating even fur-
ther their behavior relatively to relevant tissues or cells. Although 
“non-bone” applications are quite recent, as was illustrated here 
in the fields of oncology, hematology and dermatology, there is 
now doubt that engineered (colloidal) apatite particles should, 
from now on, be considered as major systems in (nano)medicine. 
Experimental Details
The colloidal apatite particles used in the novel data reported 
in this work were synthesized using either AEP (2-aminoethyl-
phosphate) or PEGp (phosphonated polyethyleneglycol, MW 
5200g/mol) as stabilizing agents, as previously published [21,31], 
and the colloids were purified by dialysis as already reported [36]. 
Raman spectra were recorded on a Labram HR800 Horiba Jobin 
Yvon confocal microspectrometer using a green laser (wavelength 
532 nm, 13 mW, 600 lines/mm), and processed using the LabS-
pec6 software. A x100 lens with 0.9 numerical aperture led to late-
ral resolution of 0.7μm and axial resolution of 2.6μm. The Raman 
3D mapping of skin explant after colloid application was obtained 
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with a red 532 nm laser (13 mW) with a 3μm pitch and 3s acquisi-
tion time in 1 accumulation. The porcine ear skin explant was used 
after biopsy: after cutting a relevant section, it was placed in resin 
molds (Tissue-Tek® OCT) and frozen at -80°C in isopentane. Sec-
tions 5 μm thick were sliced using a cryostat (Leica CM 1950), for 
analysis. Histological observations were carried out at the CPTP 
laboratory, Toulouse, France. The tissues were dehydrated in two 
successive absolute ethanol baths, followed by 2 xylene baths, and 
mounted on slats with Eukitt resin. µPIXE analyses were carried 
out on the AIFIRA facility (CENBG, France). Cells (HUVEC) were 
cultured directly onto ion beam microprobe sample holders as 
adapted from previous studies [37]. Briefly, cells were directly 
grown at high confluence on 2µm-thick polycarbonate foil for 24 
hours in appropriate culture medium, and then exposed to 0.1 or 
0.5 mg/L (as indicated in the text) of colloidal apatite particles 
doped with 25 or 50 at.% of strontium (replacing calcium in the 
apatite formula). 
Cells exposed to only the aqueous medium containing hexa-
metaphosphate 0.1 or 0.5 mg/L; HMP being used as redispersing 
agent in the formulation of the AEP-stabilized particles [21], were 
used as a control. Cells were rinsed once in culture medium, and 
very briefly rinsed twice in ultrapure water to remove excess 
of extracellular salts from culture medium. Finally, cells were 
plunge-freezed at -150°C into liquid nitrogen chilled 2-methylbu-
tan (ReagentPlus, ≥99%, Sigma-Aldrich) and freeze-dried using 
a freeze-dryer (Christ alpha, ThermoFischer Scientific) in two 
phases: A phase of primary desiccation of 12 to 24 hours (T°C = 
-99°C, P = 0.001mbar) followed by a phase of secondary desicca-
tion of 24 hours (T°C = +40°C, P = 0.001mbar). With no contami-
nation and no ionic diffusion, freeze-drying was found to be the 
most adapted process. The samples were then kept at room tem-
perature in a desiccator prior to PIXE analyses. The Sr, Ca, P, K, Al 
and Si elements were followed by PIXE using an incident proton 
beam of 1.5MeV, a beam diameter of 1 µm and an intensity of 150 
pA. The scanned typical size was of 14µm, with an acquisition time 
of about 1h45 per zone. Protocols are described in previous works 
[37-39]. For the study on the effect of formulation, an alginate gel 
was used, incorporating the colloidal apatite particles stabilized 
by PEGp 5200 g/mol. To form the gel, 3% m/v of sodium alginate 
was added to the colloid using an Ultra-turrax® mixer at a speed 
of 6000 rpm. 
For the gel containing only dissolved folic acid (FA), a solution 
of FA at 200 mg/L, pH 7.4 was prepared and calcium ions were 
added in the form of calcium chloride (7.5 mmol/L) to reach si-
milar viscosity of the colloids, and sodium alginate was added as 
previously (3% m/v, Ultra-turrax® 6000 rpm). The permeation 
of FA (or FA-loaded particles) across two synthetic hydrophilic 
membranes with different porosities (polycarbonate: 0.05 µm 
and cellulose acetate: 0.2 µm) was monitored by UV spectrosco-
py (Shimadzu UV-160A, λ = 280 nm). Adsorption of FA onto the 
surface of the colloidal apatite particles was obtained by the ad-
dition of FA in the calcium salt solution prior to colloid formation 
(0.011mmol of FA for 4.87 mmol of Ca(NO3)2 . 4H2O). Permea-
tion test cells developed at the Department of Chemistry and 
Pharmacy of the University of Sassari, Italy, [Italian Patent No. 
102017000089514, granted on 10/17/2019, International Appli-
cation No. PCT/IB2018/055726»PERMEATION TEST CELL», were 
used in this work as permeation system in dynamic conditions. 
It consists in three parallel thermostated permeation cells of ver-
tical-diffusion type (32.0±0.5°C, approaching normal skin tempe-
rature) characterized by a diffusion area of 3.14 cm². Each cell is 
composed of an upper (donor) compartment on which the col-
loid/gel is applied and of a lower (receiver) compartment where 
the FA concentration is measured. The recipient compartments 
were initially filled with buffer solution (250 mL of KH2PO4 0.2 M, 
195.5 mL of NaOH 0.2M, deionized water up to 1L, pH close to the 
physiological) and magnetically stirred. The cells were connec-
ted to a peristaltic pump for providing dynamic circulation (total 
volume 50 mL, flowrate  6 mL/min) and to the UV-visible spec-
trophotometer (Shimadzu UV-160 A) as in-line drug monitoring 
system. An initial volume of 1ml colloid/gel was placed on the do-
nor compartments at the start of the experiments. All experiments 
were done in triplicate.
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